EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...

Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...

The breakthrough should help advance our understanding into how human heart valves develop,...

Content from other channels on our network

Doctor convicted after writing 147 scripts for 96 patients while suspended

Sale of Hobart Private Hospital to Calvary raises concerns

Opinion: The growing risk of AI-driven self-diagnosis in breast health

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Engineers Australia supports national engineer registration

Asahi to use recycled material for all plastic soft drink bottles

Queensland Government and CSIRO launch free R&D program for SMEs

Applications open in WA for submarine sustainment contracts

Construction begins on WA gallium project

APPEX 2027: The Industry Event Powered by APPMA Returns to Melbourne

From bottleneck to backbone: rethinking water in F&B manufacturing

Barry Callebaut appoints new Chief Operating Officer

Arnott's Group celebrates its suppliers at Sydney event

Record growth for food and grocery manufacturing sector, AFGC reports